NEUROBO PHARMACEUTICALS INC - COM (NRBO)

CUSIP: 64132R107

Q1 2021 13F Holders as of 31 Mar 2021

Share change
+725,930
Put/Call ratio
12%
SEC-reported price per share
$4.40
Number of holders
28
Value change
+$2,973,911
Number of buys
19
Open additional details 1 more signal available
Number of sells
10

Security key

64132R107

Report period

Q1 2021

Institutions

28

Top holders

10

Ownership snapshot

Top reported holders of NRBO - NEUROBO PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $1,154,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $1.15M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $1.15M
SABBY MANAGEMENT, LLC $748K
NORTHERN TRUST CORP $425K
STATE STREET CORP $243K
Anson Funds Management LP $239K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$1,154,000
219,989 shares
— 31 Dec 2020
SABBY MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$748,000
142,400 shares
— 31 Dec 2020
NORTHERN TRUST CORP
13F
Company
13F
—
denominator unverified
$425,000
80,860 shares
— 31 Dec 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$243,000
46,357 shares
— 31 Dec 2020
Anson Funds Management LP
13F
Company
13F
—
denominator unverified
$239,000
45,489 shares
— 31 Dec 2020
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$216,000
41,294 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
28
Shares
1,491,006
Rows available
28
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders
28
Q1 2021 holders
28
Holder diff
0
Investor Q1 2021 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2021 value Q1 2021 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .